These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9414411)

  • 1. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
    Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
    J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions].
    Miyahara E; Yamaguchi Y; Hihara J; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1622-5. PubMed ID: 7574776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
    Ikeda H; Sato N; Matsuura A; Kikuchi K
    Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
    Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
    J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients.
    Miyahara E; Yamaguchi Y; Minami K; Hihara J; Noma K; Toge T; Takafuta T; Fujimura K
    Anticancer Res; 1999; 19(3A):2057-66. PubMed ID: 10470148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usage of T cell receptor (TCR) V beta gene in ulcerative colitis.
    Shigematsu M; Masuda H
    J Clin Lab Immunol; 1996; 48(5):177-86. PubMed ID: 9394241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
    Uchida A; Micksche M; Hoshino T
    Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
    Kan N
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
    Uchida A
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Restricted usage of repertoire of T-cell receptor V beta in Chinese asthmatics].
    Guo X; Li W; Deng W; Ni P; Yu S; Li Y; Zhang H
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):78-80. PubMed ID: 11953102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
    Kan N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
    Uchida A; Micksche M
    J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
    Hihara J; Yamaguchi Y; Minami K; Noma K; Toge T
    Anticancer Res; 1999; 19(2A):1077-84. PubMed ID: 10368657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
    Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
    Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal expansion of T cells that are specific for autologous ovarian tumor among tumor-infiltrating T cells in humans.
    Hayashi K; Yonamine K; Masuko-Hongo K; Iida T; Yamamoto K; Nishioka K; Kato T
    Gynecol Oncol; 1999 Jul; 74(1):86-92. PubMed ID: 10385556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
    Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratumoral administration of OK432 in rats with liver tumor].
    Ishimaru M
    Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):880-8. PubMed ID: 2972906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T cell receptors reactive with squamous cell carcinoma antigen SART-1 presented by the HLA-A24 molecule.
    Shimizu K; Yamaguchi Y; Ohta K; Miyahara E; Toge T
    Oncol Rep; 2002; 9(3):599-605. PubMed ID: 11956635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.